86profile quality
Boehringer Ingelheim Venture Fund is an evergreen fund established in 2010 that invests in pioneering science and first-in-class, disease-modifying therapeutic innovations to redefine the standard of care.
biotechtherapeuticsdrug-developmentdrug-discoveryhealthcare
No structured research canvas has been published for this profile yet. The overview reflects the imported public record.
- 1X Photographyfounded